Revivo Therapeutics Employee Directory
Biotechnology ResearchUnited States2-10 Employees
Clinical stage biotechnology company developing a new class of cognitive enhancing small molecules targeting cognitive decline. Our first drug candidate RIV-5061 targets the treatment of Mild Cognitive Impariment. We are in the process of raising funding for Phase 1/1b clinical trials.